VRAX (Virax Biolabs Group Limited) stock: $0.79, $1.1M market cap, $4.2M cash, -$2.8M EV, $1.1M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
What they do
Virax Biolabs Group Limited is a holding company incorporated as an exempted company under the laws of the Cayman Islands. As a holding company with no material operations of its own, we conduct substantially all of our operations through subsidiaries in the United Kingdom, the United States and China.
Estimated readout windows: registry primary-completion date + 6-12 weeks. Windows already open are shown from "Now". Drug names link to ClinicalTrials.gov.